Comparison 8. Bexarotene + PUVA vs PUVA alone.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
8.1 Common adverse events	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1.1 Liver toxicities	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1.2 Renal toxicity	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1.3 Haematological toxicities	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1.4 Increased fasting cholesterol	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1.5 Photosensitivity	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1.6 Pruritus	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1.7 Rash	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.1.8 Hypertriglyceridaemia	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
8.2 Complete response	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
8.3 Objective response rate	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only